The drug development process in the United States has become so weighted down by a business-as-usual paradigm that an average of more than $2 billion is spent to secure FDA approval for every new drug. Because the investment required is so extreme, drug development companies are understandably focused on discovering and developing drugs designed for large patient populations: diseases experienced by millions, such as high blood pressure, diabetes, or some of the more common cancers. In Unnecessary Expense, Dr. Charles ...
Read More
The drug development process in the United States has become so weighted down by a business-as-usual paradigm that an average of more than $2 billion is spent to secure FDA approval for every new drug. Because the investment required is so extreme, drug development companies are understandably focused on discovering and developing drugs designed for large patient populations: diseases experienced by millions, such as high blood pressure, diabetes, or some of the more common cancers. In Unnecessary Expense, Dr. Charles Theuer, CEO of TRACON Pharmaceuticals, outlines the problem and offers a solution: an aligned and streamlined model that emphasizes quality and reduces the time and cost of drug development, while also harnessing global innovation to benefit patients with rare diseases in urgent need of new treatments. Here Dr. Theuer shows the value of a pharmaceutical paradigm shift, to enable the development of drugs for patients who need them, at a fraction of the time and cost.
Read Less
Add this copy of Unnecessary Expense: an Antidote for the Billion Dollar to cart. $19.99, new condition, Sold by Websew Inc rated 4.0 out of 5 stars, ships from Avenel, NJ, UNITED STATES, published 2021 by Forbesbooks.
Add this copy of Unnecessary Expense: An Antidote for the Billion Dollar to cart. $21.22, new condition, Sold by Ingram Customer Returns Center rated 5.0 out of 5 stars, ships from NV, USA, published 2021 by Forbesbooks.
Add this copy of Unnecessary Expense: An Antidote for the Billion Dollar to cart. $21.71, new condition, Sold by GreatBookPrices rated 4.0 out of 5 stars, ships from Columbia, MD, UNITED STATES, published 2021 by Forbesbooks.
Choose your shipping method in Checkout. Costs may vary based on destination.
Seller's Description:
New. Sewn binding. Cloth over boards. 192 p. In Stock. 100% Money Back Guarantee. Brand New, Perfect Condition, allow 4-14 business days for standard shipping. To Alaska, Hawaii, U.S. protectorate, P.O. box, and APO/FPO addresses allow 4-28 business days for Standard shipping. No expedited shipping. All orders placed with expedited shipping will be cancelled. Over 3, 000, 000 happy customers.
Add this copy of Unnecessary Expense: An Antidote for the Billion Dollar to cart. $21.99, new condition, Sold by Ambis Enterprises LLC rated 3.0 out of 5 stars, ships from Benton Harbor, MI, UNITED STATES, published 2021 by Forbesbooks.
Choose your shipping method in Checkout. Costs may vary based on destination.
Seller's Description:
New. Brand New! Not Overstocks or Low Quality Book Club Editions! Direct From the Publisher! We're a small town bookstore that loves books and loves it's customers! Buy from US! Sewn binding. Cloth over boards. 192 p.
Add this copy of Unnecessary Expense: an Antidote for the Billion Dollar to cart. $23.15, new condition, Sold by BargainBookStores rated 3.0 out of 5 stars, ships from Grand Rapids, MI, UNITED STATES, published 2021 by Forbesbooks.
Add this copy of Unnecessary Expense: an Antidote for the Billion Dollar to cart. $29.69, new condition, Sold by Ebooksweb rated 3.0 out of 5 stars, ships from Bensalem, PA, UNITED STATES, published 2021 by Forbesbooks.
Add this copy of Unnecessary Expense to cart. $34.93, new condition, Sold by Paperbackshop rated 4.0 out of 5 stars, ships from Bensenville, IL, UNITED STATES, published 2021 by Advantage Media Group, Inc.